Tag: IDE

Endologix announces completion of enrollment in TORUS 2 study for PAD...

Endologix has completed enrollment in the TORUS 2 investigational device exemption (IDE) clinical study in the U.S., a press release reports. The TORUS 2 study...

VenoValve: Chronic venous insufficiency device gains brisk double of first US...

Hancock Jaffe Laboratories recently revealed that the United States Patent and Trademark Office (USPTO) issued the first patent covering the company’s VenoValve. The patent is...

Treo IDE primary endpoint results announced

In the wake of approval by the Food and Drug Administration (FDA) of the Treo abdominal aortic stent-graft system for the treatment of patients...

FDA grants Nexus aortic arch stent graft system breakthrough designation

Endospan was recently granted breakthrough device designation from the Food and Drug Administration (FDA) for the Nexus aortic arch stent graft system. The FDA’s breakthrough...

Aortic neck dilation after FEVAR leads to little clinical impact, new...

MIAMI—Data, gathered in a study on the impact of aortic neck dilation after fenestrated endovascular aortic aneurysm repair (FEVAR), show that the process does...